J&J, Hacker Work Together To Fix Insulin Pump Vulnerability
US FDA says the collaborative approach taken by an independent security researcher and Johnson & Johnson/Animas in responding to a potentially fatal cybersecurity vulnerability with the firm's Animas OneTouch Ping insulin pump should be a model for the industry that aligns with the agency's recent draft guidance.
You may also be interested in...
A public-private partnership board long touted by top US FDA officials to help address cybersecurity threats has hit a funding wall. The agency received less than half of what it asked for in the FY 2019 budget for its digital efforts, including its cybersecurity strategy, leading it to make some tough choices.
A center inside the US Department of Homeland Security has seen a massive spike in the number of potential medical device cybersecurity vulnerabilities that it has responded to in the past year. The government says it reflects better collaboration and disclosure policies in industry.
If Congress approves a 26% higher 2019 funding request for US FDA's device center, a substantial chunk of those dollars would go to building a novel framework for regulating digital-health technologies, and to help FDA and device manufacturers respond better to cybersecurity vulnerabilities, among other program priorities, according to agency officials.